PTC Therapeutics director Michael Schmertzler reports sale of common shares worth $149,036.84
PTCT•PTC Therapeutics director Michael Schmertzler sold 2,500 shares on October 14, 2026, for a total of $149,036.84. After the sales, he held 1,291,594 shares indirectly and 163,266 directly.
1. Share sale details
Schmertzler sold 2,500 common shares through indirect holdings on October 14, 2026: 2,118 shares at $59.52 each and 382 at $60.14 each. Following the transactions, he held 1,291,594 shares indirectly and 163,266 shares directly.
